Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Juvista (avotermin) for improvement of scar appearance after bilateral reduction mammaplasty
2005-004265-42Phase 2Terminated
- Sponsor
- Renovo
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Pathological scar comparing Juvista (avotermin) with Placebo (2 arms). Primary endpoint: Combined Total Scar Score (ToScar) VAS up to Month 7. Started Jan 2006; status: terminated.
02
Drugs
avotermin
03
Conditions
Pathological scar
Beyond the preview
Go deeper on 2005-004265-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004265-42.